2020
DOI: 10.1002/sim.8481
|View full text |Cite
|
Sign up to set email alerts
|

A threshold‐free summary index for quantifying the capacity of covariates to yield efficient treatment rules

Abstract: When data on treatment assignment, outcomes, and covariates from a randomized trial are available, a question of interest is to what extent covariates can be used to optimize treatment decisions. Statistical hypothesis testing of covariate‐by‐treatment interaction is ill‐suited for this purpose. The application of decision theory results in treatment rules that compare the expected benefit of treatment given the patient's covariates against a treatment threshold. However, determining treatment threshold is oft… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 33 publications
(76 reference statements)
0
2
0
Order By: Relevance
“…For evaluating the discriminatory performance of benefit predictors, there are alternative metrics that are not suffering from these issues identified in this work. One particular metric is the Concentration of Benefit ( ) [ 6 ]. is directly related to the Gini index and is concerned about the dispersion of the distribution of .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For evaluating the discriminatory performance of benefit predictors, there are alternative metrics that are not suffering from these issues identified in this work. One particular metric is the Concentration of Benefit ( ) [ 6 ]. is directly related to the Gini index and is concerned about the dispersion of the distribution of .…”
Section: Discussionmentioning
confidence: 99%
“…The treatment benefit paradigm can incorporate these concepts. For example, calibration plots [ 4 ], discriminatory performance measures [ 5 , 6 ], and net benefit [ 7 ] have been extended to evaluate treatment benefit predictors. Maas et al further extended other performance measures, such as E-statistic, cross-entropy, and Brier score, to treatment benefit predictors [ 8 ].…”
Section: Introductionmentioning
confidence: 99%